263 related articles for article (PubMed ID: 9614013)
1. Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.
Olujohungbe A; Cinkotai KI; Yardumian A
BMJ; 1998 Jun; 316(7146):1689. PubMed ID: 9614013
[No Abstract] [Full Text] [Related]
2. Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.
Obaro SK
Lancet Glob Health; 2015 Mar; 3(3):e124-5. PubMed ID: 25701988
[No Abstract] [Full Text] [Related]
3. Hydroxyurea in very young children with sickle cell anemia is not a cure-all.
Powars DR
J Pediatr; 2001 Dec; 139(6):763-4. PubMed ID: 11743496
[No Abstract] [Full Text] [Related]
4. Hydroxyurea for sickle cell anemia.
Bachmeyer C; Aractingi S; Lionnet F
N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18609755
[No Abstract] [Full Text] [Related]
5. Hydroxurea and sickle cell disease: Its been a long, long time coming.
Scott JP
Pediatr Blood Cancer; 2010 Feb; 54(2):185-6. PubMed ID: 19908298
[No Abstract] [Full Text] [Related]
6. Hydroxyurea for the treatment of sickle cell anemia.
Platt OS
N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
[No Abstract] [Full Text] [Related]
7. Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi.
Mvalo T; Topazian H; Kamthunzi P; Chen J; Kambalame I; Mafunga P; Mumba N; Chiume-Chiphaliwali M; Paseli K; Key N; Gopal S; Hoffman I; Ataga K; Westmoreland K
Blood Adv; 2018 Nov; 2(Suppl 1):30-32. PubMed ID: 30504195
[No Abstract] [Full Text] [Related]
8. Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease.
Gille AS; Pondarré C; Dalle JH; Bernaudin F; Chalas C; Fahd M; Jean C; Lezeau H; Riou L; Drouineaud V; Paye-Jaouen A; Kamdem A; Neven B; Arnaud C; Azarnoush S; Yakouben K; Sarnacki S; de Montalembert M; Comperat EM; Lenaour G; Sibony M; Dhédin N; Vaiman D; Wolf JP; Patrat C; Fouchet P; Poirot C; Barraud-Lange V
Blood; 2021 Feb; 137(6):856-859. PubMed ID: 33259585
[No Abstract] [Full Text] [Related]
9. [Edifying affair of hydroxycarbamid].
Nau JY
Rev Med Suisse; 2008 Apr; 4(152):940. PubMed ID: 18578439
[No Abstract] [Full Text] [Related]
10. Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia.
Taylor JG; Darbari DS; Maric I; McIver Z; Arthur DC
Ann Intern Med; 2011 Nov; 155(10):722-4. PubMed ID: 22084346
[No Abstract] [Full Text] [Related]
11. The role of hydroxyurea in sickle cell disease.
Halsey C; Roberts IA
Br J Haematol; 2003 Jan; 120(2):177-86. PubMed ID: 12542474
[No Abstract] [Full Text] [Related]
12. Hydroxycarbamide for sickle-cell anaemia in infancy.
Weatherall DJ
Lancet; 2011 May; 377(9778):1628-30. PubMed ID: 21571132
[No Abstract] [Full Text] [Related]
13. Sickle cell pain crisis.
Davies SC; Bevan DH
Lancet; 1996 Jan; 347(8996):263. PubMed ID: 8551907
[No Abstract] [Full Text] [Related]
14. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.
Brawley OW; Cornelius LJ; Edwards LR; Gamble VN; Green BL; Inturrisi C; James AH; Laraque D; Mendez M; Montoya CJ; Pollock BH; Robinson L; Scholnik AP; Schori M
Ann Intern Med; 2008 Jun; 148(12):932-8. PubMed ID: 18458271
[No Abstract] [Full Text] [Related]
15. Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease.
Brandow AM; Panepinto JA
Am J Hematol; 2011 Sep; 86(9):804-6. PubMed ID: 21815183
[TBL] [Abstract][Full Text] [Related]
16. Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea.
Tripathi A; Jerrell JM; Stallworth JR
Pediatr Blood Cancer; 2011 Jan; 56(1):90-4. PubMed ID: 20922765
[TBL] [Abstract][Full Text] [Related]
17. Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease.
Hoppe C; Vichinsky E; Quirolo K; van Warmerdam J; Allen K; Styles L
J Pediatr Hematol Oncol; 2000; 22(4):330-4. PubMed ID: 10959903
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a review.
DeBaun MR
Expert Rev Hematol; 2014 Dec; 7(6):767-73. PubMed ID: 25242414
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea therapy for sickle cell anemia.
McGann PT; Ware RE
Expert Opin Drug Saf; 2015; 14(11):1749-58. PubMed ID: 26366626
[TBL] [Abstract][Full Text] [Related]
20. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].
Nkashama GM; Wakamb GK; Mulangu AM; Nkashama GM; Kupa BK; Numbi OL
Pan Afr Med J; 2015; 21():124. PubMed ID: 26327961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
